GOODOVA L 2.5

About

GOODOVA L 2.5 contains Letrozole 2.5mg, an oral non-steroidal aromatase inhibitor primarily recognized for its role in treating hormone-sensitive breast cancer in postmenopausal women. In the realm of reproductive health, this lower dose is frequently prescribed off-label for ovulation induction in women facing infertility challenges, especially those with anovulatory disorders such as polycystic ovary syndrome (PCOS). The mechanism involves a transient reduction in estrogen levels, which in turn prompts the pituitary gland to secrete higher amounts of follicle-stimulating hormone (FSH). This surge in FSH promotes the growth and maturation of ovarian follicles, leading to ovulation and significantly improving the chances of conception, making it a key medication in fertility protocols.

Uses

• Treatment of early or advanced breast cancer.
• Ovulation induction for infertility.
• Management of anovulatory disorders like PCOS.
• Stimulation of ovarian follicles.

Directions For Use

Take one tablet orally once daily for 5 days, starting on day 3-5 of the menstrual cycle, or as directed by your specialist.

Benefits

• Effective in treating certain breast cancers.
• Induces ovulation in anovulatory women.
• Lower risk of ovarian hyperstimulation.
• Well-tolerated with fewer side effects than some alternatives.
• Supports successful conception.
• Helps regulate hormonal balance.

Side Effects

• Hot flashes
• Fatigue
• Headache
• Nausea
• Dizziness
• Joint pain
• Muscle pain
• Insomnia
• Vaginal dryness
• Mood disturbances
• Mild abdominal discomfort
• Hair loss (rare)

Safety Measures

• Alcohol - No specific contraindications, but may worsen dizziness or fatigue in some individuals.
• Pregnancy - Strictly contraindicated during pregnancy due to potential teratogenic effects; ensure effective contraception.
• Breastfeeding - Not recommended during breastfeeding as it may be excreted in breast milk and harm the infant.
• Liver - Use with caution and potential dose adjustment in patients with severe hepatic impairment.
• Kidney - Generally safe, but caution is advised in severe renal impairment; no dose adjustment typically needed for mild to moderate.
• Lung - No specific contraindications or precautions related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.